Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SYNCHRONICITY: A Study to Evaluate the Effectiveness of Aranesp® at 300 Mcg Q3W on Clinical Outcomes in Cancer Patients With Anemia Due to Chemotherapy

NCT00117039 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00117039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00117039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SYNCHRONICITY: A Study to Evaluate the Effectiveness of Aranesp® at 300 Mcg Q3W on Clinical Outcomes in Cancer Patients With Anemia Due to Chemotherapy
Lead sponsor
Amgen
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2004
Completion date
April 30, 2005
Enrollment
1,500
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, neoplasms